3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
13
Burkitt Lymphoma
9
Lung Neoplasms
7
Lymphoma, Non-Hodgkin
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Non-Small-Cell Lung
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma
4
Hodgkin Disease
4
Sarcoma, Ewing
3
Recurrence
3
Plasmablastic Lymphoma
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Leukemia
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Immunoblastic Lymphadenopathy
2
HIV Infections
2
Ganglioneuroblastoma
2
Congenital Abnormalities
2
Central Nervous System Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
3
ulixertinib
2
dabrafenib
2
binimetinib
2
Surveys and Questionnaires
2
Sunitinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cetuximab
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
temsirolimus
1
selpercatinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
gallium Ga 68 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Etoposide
×
30 days
×
Clear all
No trials found.